• Notice

Type(s) de contenu et mode(s) de consultation : Texte noté : électronique

Titre(s) : Pharmacology of itch [Texte électronique] / Alan Cowan, Gil Yosipovitch, editors

Publication : Heidelberg : Springer, cop. 2015

Description matérielle : 1 ressource dématérialisée

Collection : Handbook of experimental pharmacology ; volume 226


Note(s) : Includes bibliographical references and index
"Basic research on the pharmacology of itch has exploded in the wake of two very influential papers that were published in Nature (2007) and Science (2009). Long overlooked as a milder form of pain, itching has rapidly gained a new appreciation in both research and clinical communities because of its complexity and its negative effects on the quality of life of the distressed patients. Like pain, not all itches are the same. Unlike pain, there are no standard drugs equivalent to aspirin and morphine. Epidemiological studies emphasize the high incidence and economic costs of itch (pruritus). It is the most prevalent symptom of a wide variety of allergic and inflammatory skin conditions (e.g., psoriasis, atopic dermatitis), is associated with several systemic diseases (e.g., chronic kidney and liver disease), and occurs in patients undergoing hemodialysis, spinal administration of opioids, and in those suffering from AIDS. The reader will learn about the multiple pathways for itch and their interactions with pain. The relationship between these closely related, yet distinct sensory phenomena, will be emphasized. Both itch and pain use several common molecules to send signals to the brain. Thus, drugs that have been, and are being, developed as analgesics may also attenuate intractable itch. This has been an exciting and very necessary turn of events since traditional H-1 receptor antagonists are ineffective in blocking the pruritus associated with kidney failure and cholestasis. The clinical chapters will provide insights into contemporary treatment regimens for pruritus in different human scenarios"--Publisher's description


Autre(s) auteur(s) : Cowan, Alan (1942-....). Fonction indéterminée  Voir les notices liées en tant qu'auteur
Yosipovitch, Gil (1961-....). Fonction indéterminée  Voir les notices liées en tant qu'auteur


Sujet(s) : Prurits  Voir les notices liées en tant que sujet


Identifiants, prix et caractéristiques : ISBN 9783662446058

Identifiant de la notice  : ark:/12148/cb447132717

Notice n° :  FRBNF44713271 (notice reprise d'un réservoir extérieur)



Table des matières : Historical background of itch ; Pruritus epidemiology and quality of life ; Neurophysiology and itch pathways ; Neuroimaging of itch as a tool of assessment of chronic itch and its management ; The role of the Mrgpr receptor family in itch ; Transient receptor potential channels and itch: how deep should we scratch? ; Itch control by toll-like receptors ; Transmission of pruriceptive signals ; Role of cytokines and chemokines in itch ; Interactions between keratinocytes and somatosensory neurons in itch ; Itch and its inhibition by counter stimuli ; Noradrenergic modulation of itch transmission in the spinal cord ; Protease-activated receptors and itch ; NK-1 antagonists and itch ; Antihistamines and itch ; Targeting itch with ligands selective for [kappa] opioid receptors ; Neuraxial opioid-induced itch and its pharmacological antagonism ; Current topical and systemic therapies for itch ; Atopic itch in dogs: pharmacology and modeling.

Localiser ce document(1 Exemplaire)

Document numérique : 

1 partie d'exemplaire regroupée

ACQNUM-95037
support : document électronique dématérialisé